Last reviewed · How we verify

Boniva — Competitive Intelligence Brief

Boniva (IBANDRONIC ACID) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bisphosphonate. Area: Bone.

marketed Bisphosphonate Farnesyl pyrophosphate synthase Bone Small molecule Live · refreshed every 30 min

Target snapshot

Boniva (IBANDRONIC ACID) — Hoffmann La Roche.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Boniva TARGET IBANDRONIC ACID Hoffmann La Roche marketed Bisphosphonate Farnesyl pyrophosphate synthase 2003-01-01
Zometa ZOLEDRONIC ACID Novartis marketed zoledronic acid Farnesyl pyrophosphate synthase 2001-01-01
Fosamax ALENDRONIC ACID Merck And Co Inc marketed Vitamin D [EPC] Farnesyl pyrophosphate synthase 1995-01-01
Aredia PAMIDRONIC ACID marketed Bisphosphonate Farnesyl pyrophosphate synthase 1991-01-01
Risedronate Risedronate Toronto Rehabilitation Institute marketed Butyrophilin subfamily 3 member A1, Farnesyl pyrophosphate synthase, Farnesyl diphosphate synthase
ibandronate [Bonviva/Boniva] ibandronate [Bonviva/Boniva] Hoffmann-La Roche marketed Bisphosphonate Farnesyl pyrophosphate synthase (indirect); hydroxyapatite in bone (binding site)
Technescan Pyp sodium pyrophosphate marketed Farnesyl pyrophosphate synthase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Bisphosphonate class)

  1. · 2 drugs in this class
  2. Amgen · 2 drugs in this class
  3. National Taiwan University Hospital · 2 drugs in this class
  4. Sanofi · 2 drugs in this class
  5. Ludwig-Maximilians - University of Munich · 2 drugs in this class
  6. Chinese University of Hong Kong · 1 drug in this class
  7. Chinese Society of Lung Cancer · 1 drug in this class
  8. Aarhus University Hospital · 1 drug in this class
  9. Eisai Inc. · 1 drug in this class
  10. Daiichi Sankyo Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Boniva — Competitive Intelligence Brief. https://druglandscape.com/ci/ibandronic-acid. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: